Hypertension
5 COMMENTS - Feb 2, 2010 14:00 EST
Low-risk hypertensive patients taking a combination of diuretics and calcium-channel blockers had a higher risk of MI than users of other common two-drug BP-lowering regimens in a new case-control study. The authors say a large clinical trial is needed to examine the best options for second-line therapy; others disagree.

Seattle, WA - Low-risk hypertensive patients taking a combination of diuretics and calcium-channel blockers (CCBs) had a higher risk of MI than users of other common two-drug BP-lowering regimens in a new case-control study published online January 25, 2010 in BMJ [1].

Lead author Dr Inbal Boger-Megiddo (University of Washington, Seattle) told heartwire she cannot determine "whether the findings indicate a positive effect of one group of drugs or a negative effect of another." But the new study "raises a good clinical question that we should address in further trials," she says. "We should definitely look into secondary hypertension and the fact that all drug groups, while being comparable in terms of their BP-lowering effects, are not necessarily comparable in terms of cardiovascular outcomes."Read full article »

Inside: Hypertension
Accredited educational programs, supported by industry, developed by theheart.org

 
Heart failure
Feb 8, 2010 17:00 EST
African American women have much higher odds of developing peripartum cardiomyopathy than non-African Americans, a new US study shows; the findings illustrate that race is by far the largest risk factor for this disease, say the researchers.
Clinical cardiology
Feb 8, 2010 17:00 EST
Two doctors from Mozambique are calling for concerted efforts to foster multidisciplinary research into neglected cardiovascular diseases that predominantly occur in Africa. These include newly emerging cardiac manifestations of infectious diseases, say the authors.
Arrhythmia/EP
1 COMMENT - Feb 3, 2010 17:15 EST
Easily added to any other tests performed, a positive finding suggests the patient is susceptible to potentially fatal ventricular arrhythmias, according to researchers.
News
1 COMMENT - Feb 3, 2010 14:30 EST
A study comparing cardiovascular outcomes at the "best hospitals," according to two popular hospital ranking systems, shows that the systems do identify high-quality hospitals, but not all of them.
News
Feb 2, 2010 16:15 EST
The number of deaths predicted would be half as high, if the US population met goals set out 10 years ago in the Healthy People 2010 report, researchers say. Obesity and diabetes have proved to be the major obstacles.
Clinical cardiology
Feb 1, 2010 17:00 EST
More than 15 million people in the US alone take herbal remedies and/or vitamins at doses that may be interacting with their cardiovascular medications, potentially putting them at risk.
Features
19 COMMENTS - Jan 29, 2010 14:15 EST
Most experts agree that reducing salt intake will cut blood pressure and in turn reduce the number of heart attacks and strokes. But messages to limit the amount of salt added to food have had little impact on sodium intake in the West, as more than 75% of salt in the diet there is contained in readily prepared foods. The UK has recently gotten tough with the food industry and cut salt intake by 10%; is it time the US and others took a similar stance? heartwire examines the issues.
Hypertension
1 COMMENT - Jan 28, 2010 13:30 EST
A new review of the use of beta blockers as second-line therapy for primary hypertension has shown that they appear to lower BP differently from thiazide diuretics, with less of an effect on pulse pressure.
Hypertension
Jan 28, 2010 09:30 EST
Although ARBs bested ACE inhibitors in this observational cohort, the data suggest that the lowest risks for Alzheimer's disease and nursing-home admission were seen in those taking both agents.
Hypertension
Jan 27, 2010 12:45 EST
The ENCORE study, illustrating how weight management augments the blood-pressure-lowering effects of the DASH diet, has been published.
News
9 COMMENTS - Jan 25, 2010 17:00 EST
A new review notes that unlike well-established standards for statistical significance, no guidelines exist for deciding what magnitude of difference is clinically meaningful or practically important. Composite end points and subgroup analyses also pose problems for clinicians trying to understand trial results.
Editorial Programs
Editorial series
Feb 4, 2010 15:00 EST
Dr Eric Topol talks to heartwire's Shelley Wood about remote monitoring, individualized medicine, and the changing face of cardiovascular care.
Editorial series
Dec 2, 2009 11:15 EST
AHA president Dr Clyde Yancy and CEO Nancy Brown share insights from the recent sessions and discuss ongoing initiatives with heartwire's Shelley Wood.
The Cardiology Show
3 COMMENTS - Nov 18, 2009 16:30 EST
Join Drs Valentin Fuster, Roger Blumenthal, Bob Harrington, Judith Hochman, Sanjay Kaul, Suzanne Oparil, Gregg Stone, Lynne Warner Stevenson, and Bruce Wilkoff as they discuss important news from the Scientific Sessions and tackle the issue of too little, too soon in clinical trials today.
Educational partnerships
This section is presented in collaboration with the
button
Previews
Resource center
Info from Industry